SinoMab BioScience organizacji Marża brutto
Jaka jest wartość Marża brutto organizacji SinoMab BioScience?
Wartość Marża brutto organizacji SinoMab BioScience Limited to 78.59%
Jaka jest definicja Marża brutto?
Marża brutto to różnica między przychodem a kosztem sprzedaży towarów podzielona przez przychód i wyrażona w procentach.
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Marża brutto firm w Health Care sektor na HKSE w porównaniu do SinoMab BioScience
Czym się zajmuję organizacja SinoMab BioScience?
SinoMab BioScience Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases, primarily monoclonal antibody (mAb)-based biologics. Its flagship product is SM03, a first-in-target anti-CD22 mAb, which is in Phase III clinical trial for the treatment of rheumatoid arthritis (RA), as well as in various clinical stages for other immunological diseases, such as systemic lupus erythematosus (SLE), Sjogren's syndrome (SS), and non-Hodgkin's lymphoma (NHL). The company also focuses on developing SN1011, a Bruton's tyrosine kinase inhibitor, which is Phase I clinical trial for the treatment of RA, SLE, pemphigus, multiple sclerosis, and other immunological diseases. Its products under preclinical stage comprise SM17 for the treatment of asthma and idiopathic pulmonary fibrosis; SM09 that is used for the treatment of NHL and RA; SM06 for use in treating RA, SLE, and SS; and TNF2 for the treatment of RA. The company operates in Mainland China, the Cayman Islands, and Hong Kong. SinoMab BioScience Limited was incorporated in 2001 and is headquartered in Pak Shek Kok, Hong Kong.
Firmy z marża brutto podobne do SinoMab BioScience
- Wartość Marża brutto organizacji Rua Life Sciences Plc to 78.54%
- Wartość Marża brutto organizacji Acrow Formwork and Construction Services to 78.56%
- Wartość Marża brutto organizacji Uniti to 78.57%
- Wartość Marża brutto organizacji LifeTech Scientific to 78.57%
- Wartość Marża brutto organizacji Servicenow Dl ,001 to 78.59%
- Wartość Marża brutto organizacji ServiceNow Inc to 78.59%
- Wartość Marża brutto organizacji SinoMab BioScience to 78.59%
- Wartość Marża brutto organizacji Tera Software to 78.59%
- Wartość Marża brutto organizacji i-nexus Global plc to 78.59%
- Wartość Marża brutto organizacji F-Secure Oyj to 78.60%
- Wartość Marża brutto organizacji Magellan to 78.61%
- Wartość Marża brutto organizacji Prozone Intu Properties to 78.63%
- Wartość Marża brutto organizacji Pandora AS to 78.63%